Functional effects of genetic variants in the 11β-hydroxylase (CYP11B1) gene

Clinical Endocrinology

Volumn 65, Issue 6, 2006, Pages 816-825

  Barr, Marianne ^a   MacKenzie, Scott M ^a   Wilkinson, Donna M ^a   Holloway, Christine D ^a   Friel, Elaine C ^a   Miller, Stephen ^a   MacDonald, Tom ^b   Fraser, Robert ^a   Connell, John M C ^a   Davies, Eleanor ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMINO ACID; CORTICOSTERONE; CORTODOXONE; DEOXYCORTICOSTERONE; HYDROCORTISONE; RENIN; STEROID 11BETA MONOOXYGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE; ANIMALS; BIOLOGICAL ASSAY; CASE-CONTROL STUDIES; CORTICOSTERONE; CORTODOXONE; DESOXYCORTICOSTERONE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERTENSION; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RENIN; SEQUENCE ANALYSIS, DNA; STEROID 11-BETA-HYDROXYLASE;

EID: 33751087743     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02673.x     Document Type: Article

References (45)

1. Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K. & He, J. (2005) Global burden of hypertension: analysis of worldwide data. Lancet, 365, 217-223.
2. Ward, R. (1990) Familial aggregation and genetic epidemiology of blood pressure. In: J.H. Laragh, B.M. Brenner eds. Hypertension: Pathophysiology, Diagnosis and Management. Raven Press, New York, 81-100.
3. Lim, P.O., Rodgers, P., Cardale, K., Watson, A.D. & MacDonald, T.M. (1999) Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet, 353, 40.
4. Gordon, R.D., Stowasser, M., Tunny, T.J., Klemm, S.A. & Rutherford, J.C. (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clinical and Experimental Pharmacology and Physiology, 21, 315-318.
5. Loh, K.C., Koay, E.S., Khaw, M.C., Emmaunel, S.C. & Young, W.F.J. (2000) Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. Journal of Clinical Endocrinology and Metabolism, 85, 2854-2859.
6. Rayner, B.L., Opie, L.H. & Davidson, J.S. (2000) The aldosterone/ renin ratio as a screening test for primary aldosteronism. South African Medical Journal, 90, 394-400.
7. Fardella, C.E., Mosso, L., Gomez-Sanchez, C.E., Cortez, P., Soto, J., Gomez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A. & Montero, J. (2000) Primary aldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. Journal of Clinical Endocrinology and Metabolism, 85, 1863-1867.
8. Mornet, E., Dupont, J., Vitek, A. & White, P.C. (1989) Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11)beta). Journal of Biological Chemistry, 264, 20961-20967.
9. White, P.C. & Slutsker, L. (1995) Haplotype analysis of CYP11B2. Endocrine Research, 21, 437-442.
10. Lim, P.O., MacDonald, T.M., Holloway, C.D., Friel, E.C., Anderson, N.H., Dow, E., Jung, R.T., Davies, E., Fraser, R. & Connell, J.M.C. (2002) Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio. Journal of Clinical Endocrinology and Metabolism, 87, 4398-4402.
11. Brand, E., Chatelain, N., Mulatero, P., Fery, I., Curnow, K., Jeunemaitre, X., Corvol, P., Pascoe, L. & Soubrier, F. (1998) Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 32, 198-204.
12. Paillard, F., Chansel, D., Brand, E., Benetos, A., Thomas, F., Czekalski, S., Ardaillou, R. & Soubrier, F. (1999) Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension, 34, 423-429.
13. Davies, E., Holloway, C.D., Ingram, M.C., Inglis, G.C., Friel, E.C., Morrison, C., Anderson, N.H., Fraser, R. & Connell, J.M.C. (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene Cyp11b2. Hypertension, 33, 703-707.
14. Kupari, M., Hautanen, A., Lankinen, L., Koskinen, P., Virolainen, J., Nikkila, H. & White, P.C. (1998) Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation, 97, 569-575.
15. Schunkert, H., Hengstenberg, C., Holmer, S.R., Broeckel, U., Luchner, A., Muscholl, M.W., Kürzinger, S., Döring, A., Hense, H.-W. & Riegger, G.A.J. (1999) Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation, 99, 2255-2260.
16. Tsujita, Y., Iwai, N., Katsuya, T., Higaki, J., Ogihara, T., Tamaki, S., Kinoshita, M., Mannami, T., Ogata, J. & Baba, S. (2001) Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita study. Hypertension Research, 24, 105-109.
17. Tamaki, S., Iwai, N., Tsujita, Y. & Kinoshita, M. (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension, 33, 266-270.
18. Pojoga, L., Gautier, S., Blanc, H., Guyene, T.T., Poirier, O., Cambien, F. & Benetos, A. (1998) Genetic determination of plasma aldosterone levels in essential hypertension. American Journal of Hypertension, 11, 856-860.
19. Mulatero, P., Schiavone, D., Fallo, F., Rabbia, F., Pilon, C., Chiandussi, L., Pascoe, L. & Veglio, F. (2000) CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension, 35, 694-698.
20. Bassett, M.H., Zhang, Y., Clyne, C., White, P.C. & Rainey, W.E. (2002) Differential regulation of aldosterone synthase and 11betahydroxylase transcription by steroidogenic factor-1. Journal of Molecular Endocrinology, 28, 125-135.
21. Davies, E., Holloway, C.D., Ingram, M.C., Friel, E.C., Inglis, G.C., Swan, L., Hillis, W.S., Fraser, R. & Connell, J.M.C. (2001) An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clinical Endocrinology, 54, 813-817.
22. Hautanena, A., Lankinen, L., Kupari, M., Janne, O.A., Adlercreutz, H., Nikkila, H. & White, P.C. (1998) Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. Journal of Internal Medicine, 244, 11-18.
23. Kennon, B., Ingram, M.C., Friel, E.C., Anderson, N.H., MacKenzie, S.M., Davies, E., Shakerdi, L., Wallace, A.M., Fraser, R. & Connell, J.M. (2004) Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clinical Endocrinology, 61, 174-181.
24. White, P.C. & Speiser, P.W. (1994) Steroid 11β-hydroxylase deficiency and related disorders. Endocrinology and Metabolism Clinics of North America, 23, 325-339.
25. Honda, M., Nowaczynski, W., Guthrie, G.P. Jr, Messeril, F.H., Tolis, G., Kuchel, O. & Genest, J. (1977) Response of several adrenal steroids to ACTH stimulation in essential hypertension. Journal of Clinical Endocrinology and Metabolism, 44, 264-272.
26. de Simone, G., Tommaselli, A., Rossi, R., Valentino, R., Lauria, R., Scopacasa, F. & Lombardi, G. (1985) Partial deficiency of adrenal 11β-hydroxylase - a possible cause of primary hypertension. Hypertension, 7, 613-618.
27. Connell, J.M.C., Kenyon, C., Ingram, M.C., Holloway, C.D., Jamieson, A., Panarelli, M., Inglis, G.C. & Fraser, R. (1996) Corticosteroids in essential hypertension: multiple candidate loci and phenotypic variation. Clinical and Experimental Pharmacology and Physiology, 23, 369-374.
28. Keavney, B., Mayosi, B., Gaukrodger, N., Imrie, H., Baker, M., Fraser, R., Ingram, M., Watkins, H., Farrall, M., Davies, E. & Connell, J. (2005) Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. Journal of Clinical Endocrinology and Metabolism, 90, 1072-1077.
29. Ganapathipillai, S., Laval, G., Hoffmann, I.S., Castejon, A.M., Nicod, J., Dick, B., Frey, F.J., Frey, B.M., Cubeddu, L.X. & Ferrari, P. (2005) CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. Journal of Clinical Endocrinology and Metabolism, 90, 1220-1225.
30. Inglis, G.C., Ingram, M.C., Holloway, C.D., Swan, L., Birnie, D., Hillis, W.S., Davies, E., Fraser, R. & Connell, J.M.C. (1999) Familial pattern of corticosteroids and their metabolism in adult human subjects - the Scottish Adult Twin Study. Journal of Clinical Endocrinology and Metabolism, 84, 4132-4137.
31. Fisher, A., Fraser, R., Connell, J.M.C. & Davies, E. (2000) Amino acid 147 of human aldosterone synthase and 11β-hydroxylase plays a key role in 11β-hydroxylation. Journal of Clinical Endocrinology and Metabolism, 85, 1261-1266.
32. Ye, P., Kenyon, C.J., MacKenzie, S.M., Seckl, J.R., Fraser, R., Connell, J.M.C. & Davies, E. (2003) Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II. Endocrinology, 144, 3321-3328.
33. Amin, H.K., Hoeppner, W., Shaarawy, M. & Barakat, M. (2002) Human gene mutations. Human Genetics, 210, 294-295.
34. Merke, D.P., Tajima, T., Chhabra, A., Barnes, K., Mancilla, E., Baron, J. & Cutler, J.B. Jr (1998) Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 270-273.
35. Curnow, K.M., Slutsker, L., Vitek, J., Cole, T., Speiser, P.W., New, M.I., White, P.C. & Pascoe, L. (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proceedings of the National Academy of Sciences of the United States of America, 90, 4552-4556.
36. Geley, S., Kapelari, K., Johrer, K., Peter, M., Glatzl, J., Vierhapper, H., Schwarz, S., Helmberg, A., Sippell, W.G., White, P.C. & Kofler, R. (1996) CYP11B1 mutations causing congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 81, 2896-2901.
37. Krone, N., Riepe, F.G., Gotze, D., Korsch, E., Rister, M., Commentz, J., Partsch, C.J., Grotzinger, J., Peter, M. & Sippell, W.G. (2005) Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene. Journal of Clinical Endocrinology and Metabolism, 90, 3724-3730.
38. Ravichandran, K., Boddupalli, S., Hasemann, C., Paterson, J. & Deisenhofer, J. (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science, 261, 731-736.
39. Belkina, N.V., Lisurek, M., Ivanov, A.S. & Bernhardt, R. (2001) Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. Journal of Inorganic Biochemistry, 87, 197-207.
40. Lisurek, M. & Bernhardt, R. (2004) Modulation of aldosterone and cortisol synthesis on the molecular level. Molecular and Cellular Endocrinology, 215, 149-159.
41. Gotoh, O. (1992) Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences. Journal of Biological Chemistry, 267, 83-90.
42. Halushka, M.K., Fan, J.B., Bentley, K., Hsie, L., Shen, N., Weder, A., Cooper, R., Lipshutz, R. & Chakravarti, A. (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature Genetics, 22, 239-247.
43. Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Shaw, N., Lane, C.R., Lim, E.P., Kalyanaraman, N., Nemesh, J., Ziaugra, L., Friedland, L., Rolfe, A., Warrington, J., Lipshutz, R., Daley, G.Q. & Lander, E.S. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics, 22, 231-238.
44. White, P.C., Curnow, K.M. & Pascoe, L. (1994) Disorders of steroid 11β-hydroxylase isozymes. Endocrine Reviews, 15, 421-438.
45. Joehrer, K., Geley, S., Strasser-Wozak, E.M.C., Azziz, R., Wollmann, H.A., Schmitt, K., Kofler, R. & White, P.C. (1997) CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β-hydroxylase deficiency. Human Molecular Genetics, 6, 1829-1834.